This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Implementing a zero based budgeting plan can streamline your finances. Learn the key steps to create an effective budget plan today.
22,407 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A fresh payroll report has spurred renewed doubt about U.S. job data. Wall street, analysts increasingly doubt the ac...
AI progress rests on more than cool gadgets. This infrastructure stock more sits at the backbone of data centers, clo...
Looking for fast-growing industrial mid-cap stocks with durable revenue streams? This guide breaks down two compellin...
The first half of 2026 delivered a sharp downturn for Salesforce as AI-driven disruption and market rotation shook th...
June's consumer price index fell 0.4% month over month, with core prices flat. Gasoline relief helped lower the headl...
Investors are weighing two AI powerhouses: Amazon and Alphabet. This guide breaks down which may offer the stronger p...
GE Aerospace reports a $210B backlog and a landmark cross-Atlantic hybrid-electric flight, signaling a major shift in...
Rumors swirl about a SpaceX IPO and what it means for space equities. This guide breaks down the potential good, bad,...
Meta Platforms is stepping up its AI push, pledging $115B-$135B in AI CapEx while moving to closed-source models. Inv...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...